Aaron B. Kantor, Susan E. Alters, Karen Cheal and Louis Dietz, 2004
“Immune Systems Biology: Immunoprofiling of Cells and Molecules.”, BioTechniques, 36: 520.
Susan E. Alters, Pedro Avila, Harini Govindarajan, Jun Deng, Homer Boushey and Aaron B. Kantor, 2002
“Phenotypic Profiling of Blood and Airway Secretions in Asthmatic and Healthy Subjects.”, J. Allergy Clin. Immunol. 109, S340
Susan E. Alters, Andrea Perrone, Karen Cheal and Aaron B. Kantor, 2001
“Identification of biomarkers in allergy and asthma: effects of glucocorticosteroids on cell surface and soluble factors.”, J. Allergy Clin. Immunol. 107, S164.
Ananda W. Goldrath, Karen E. Chen, Leann Barber and Susan E. Alters, 1995,
“Differences in Adhesion Markers, Activation Markers and TcR in Islet Infiltrating vs. Peripheral Lymphocytes in the NOD Mouse”, J. Autoimmunity 8:209.
Ananada W. Goldrath, Karen E. Chen, Lamont G. Weide, Parvis M. Pour, Jane S. Lebkowski and Susan E. Alters, 1995.
“Retention of Endocrine Function in the SCID-Hu Pancreas Mouse: A Model for the Development of Human Fetal Islet Tissue”, Transplantation 59:1496.
Jeffrey L. Cleland, Nathan C Geething, Jerome A Moore, Brian C. Rogers, Benjamin J Spink, Chai-wei Wang, Susan E. Alters, Willem P C Stemmer, and Volker Schellenberger, 2012
“A Novel Long-Acting Human Growth Hormone Fusion Protein (VRS-317): Enhanced In Vivo Potency and Half-Life”, Journal of Pharmaceutical Sciences, 101: 2744
Judy Shizuru, Susan E. Alters and C. Garrison Fathman, 1992.
“Anti-CD4 Monoclonal Antibodies in Therapy: Creation of Nonclassical Tolerance in the Adult”, Immunol. Rev. 129:105.
Susan E. Alters, Koichiro Sakai, Lawrence Steinman and Vernon T. Oi, 1990.
“Mechanisms of Anti-CD4 Mediated Depletion and Immunotherapy: A Study Using a Set of Chimeric Anti-CD4 Antibodies”, Journal of Immunology 14:4587.
Susan E. Alters, Lawrence Steinman and Vernon T. Oi, 1989.
“Comparison of Rat and Rat-Mouse Chimeric Anti-Murine CD4 Antibodies In Vitro: Chimeric Antibodies Lyse Low Density CD4+ Cells”, Journal of Immunology, 142:2018.
Susan E. Alters, Davida Grossman and C. Fathman, 1992.
“Anti-CD4 Mediated Transplantation Tolerance: Mechanisms and Memory.”, A Critical Analysis of Monoclonal Antibody Therapy in Transplantation, W. J. Burlingham ed, p.79-99.
Susan E. Alters, Bryant McLaughlin, Ben Spink, Tigran Lachinyan, Chia-wei Wang, Vladimir Podust, Volker Schellenberger, and William P C Stemmer, 2012
“GLP2-2G-XTEN: A Pharmaceutical Protein with Improved Serum Half-Life and Efficacy in a Rat Crohn’s Disease Model”, PLoS ONE 7(11): e50630. doi:10.1371/journal.pone.0050630
Lawrence Steinman, William Lindsey, Susan Alters and Suzanne Hodgkinson, 1993
“Anti-CD4 Therapy: From Treatment of Experimental Allergic Encephalomyelitis to Clinical Trials in Multiple Sclerosis”, Immunol. Ser. 59:253.
Alshad S Lalani, Susan E. Alters, Alvin Wong, Mark R. Albertella, Jeffrey L. Cleland, and William David Henner, 2007
“Selective Tumor Targeting by the Hypoxia-Activated Prodrug AQ4N Blocks Tumor Growth and Metastasis in Preclinical Models of Pancreatic Cancer”, Clinical Cancer Research, 13: 2216
Charles A. Wartchow, Susan E. Alters, Lingyun Li, Tina Doede, Susan J. Knox and Jeffrey L. Cleland, 2004
” Enhancement of the efficacy of an antagonist of an extracellular receptor by attachment to the surface of a biocompatible carrier.”, Pharm Res. 21:1880.
Ramila Philip, Susan E. Alters, Elisa Brunette, Jean Ashton, Jose R. Gadea, Jane Lebkowski and Mohan Philip, 2000
“Dendritic cells loaded with MART-1 peptide or infected with adenoviral construct are functionally equivalent in the induction of tumor specific CTL responses in patients with melanoma.”,
J. Immunotherapy 1:168.
Susan E. Alters, Jose R. Gadea, Jane Lebkowski and Ramila Philip, 1999
“IL13 Can Substitute for IL4 in the Generation of Dendritic Cells for Induction of CTL and Gene Therapy”, J. Immunotherapy 22:229.
Ramila Philip, Elisa Brunette, Jean Ashton, Susan Alters, Jose R. Gadea, Gerard O’Donoghue, Martin Sorich, Josephine Yau, Jane Lebkowski and Mohan Philip, 1998
“Transgene Expression in Dendritic Cells to Induce Antigen CTL in Healthy Donors”, Canc. Gene Therapy 5:236.
Susan E. Alters, Jose R. Gadea, Gerard O’Donoghue, Martin Sorich, Sohel Talib and Ramila Philip, 1998
“Dendritic Cell Induced Generation of CEA Peptide Specific CTL: Correlation of TcR Repertoire with CTL Function and Phenotype”, J. Immunotherapy 21:17.
Susan E. Alters, Jose R. Gadea and Ramila Philip, 1997
“Immunotherapy of Cancer: Generation of CEA Specific CTL Using CEA Peptide Pulsed Dendritic Cells”, Adv. Exp. Med. Biol. 417:519.
Susan E. Alters, Howard K. Song and C. Garrison Fathman, 1993.
“Evidence That Clonal Anergy Is Induced In Thymic Migrant Cells After Anti-CD4 Mediated Transplantation Tolerance.”, Transplantation 56:633.
Howard K. Song, Susan E. Alters and C. Garrison Fathman, 1993.
“Evidence that Anti-CD8 Abrogates Anti-CD4 Mediated Clonal Anergy but Allows Allograft Survival in Mice.”, Transplantation 55:133.
Susan E. Alters, Judy Shizuru, Jill Ackerman, Davida Grossman, Karl Seydel and C. G. Fathman, 1991.
“Anti-CD4 Mediates Clonal Anergy During Transplantation Tolerance Induction”, Journal of Experimental Medicine 173:491.
Karl Seydel, Judith Shizuru, Davida Grossman, Anna Wu, Susan Alters and C.G. Fathman, 1991.
“Anti-CD8 Abrogates the Effect of Anti-CD4 Mediated Islet Allograft Survival in a Rat Model”, Diabetes 40:1430